Serina Therapeutics, Inc.SERNYSE
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-sales ratio
Latest
658.37
↑ 186% above average
Average (8y)
230.38
Historical baseline
Range
High:1076.81
Low:13.80
CAGR
+35.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 658.37 | +1694.3% |
| 2023 | 36.69 | -13.7% |
| 2022 | 42.53 | +208.2% |
| 2021 | 13.80 | -98.7% |
| 2020 | 1076.81 | +2601.3% |
| 2019 | 39.86 | -47.5% |
| 2018 | 75.94 | +8.1% |
| 2017 | 70.23 | +18.7% |
| 2016 | 59.19 | - |